Skip to main content
. 2013 Mar 1;52(2):172–178. doi: 10.3164/jcbn.12-107

Table 3.

The proportions of change in patients’ scores

BE-3M BE-1Y
QOLRAD-J score
 Improvement 13/39 (33.3%) 13/35 (37.1%)
 No change 19/39 (48.7%) 17/35 (48.6%)
 Aggravation 7/39 (18.0%) 5/35 (14.3%)
CDQ score
 Improvement 13/37 (35.1%) 16/34 (47.1%)
 No change 14/37 (37.8%) 14/34 (41.2%)
 Aggravation 10/37 (27.0%) 4/34 (11.8%)

Values are n (%). BE: before the eradication therapy, 3M: 3 months after the eradication therapy, 1Y: 1 year after the eradication therapy.